Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gain Therapeutics Inc
GANXCurrent price
1.90 USD
+0.015 USD (+0.80%)
Last closed
1.85 USD
Company
www.gaintherapeutics.com
ISIN
US36269B1052
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
52 239 560 USD
Yield for 12 month
-36.83 %
1Y
3Y
5Y
10Y
15Y
GANX
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of Parkinson's disease, currently in a Phase 1b study in people with Parkinson's disease with or without a GBA1 mutation. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is based in Bethesda, Maryland. Address: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+55 180 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-25 202 USD
Current Quarter
–
Last Quarter
–
Key Figures GANX
1 year
3 years
5 years
10 years
EBITDA
-20 321 676 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-82.80 %
PEG Ratio
–
Return On Equity TTM
-204.95 %
Wall Street Target Price
8.00 USD
Revenue TTM
–
Book Value
0.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
-10 650 481 USD
Earnings per share
-0.89 USD
Diluted Eps TTM
-0.89 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GANX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History GANX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation GANX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
138.33
Price Sales TTM
255.50
Enterprise Value EBITDA
-1.55
Price Book MRQ
7.12
Financials GANX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GANX
For 52 weeks
0.89 USD
3.19 USD
50 Day MA
2.03 USD
Shares Short Prior Month
326 688
200 Day MA
1.83 USD
Short Ratio
1.22
Shares Short
302 677
Short Percent
1.14 %
BeatStart